A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
Phase 4
80
about 2.3 years
18–65
1 site in NY
What this study is about
Researchers are testing whether Rimegepant (Nurtec) is more effective than Rizatriptan (Maxalt) for treating migraines in adults who go to the Emergency Department. The trial will last 851 days and involve approximately 80 patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Rimegepant
- 2.Take Rizatriptan Benzoate
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
rimegepant, Antimigraine Agents (Serotonin 1b Receptor Agonists)
oral (Disintegrating Oral Tablet), oral (Oral Tablet)
Primary: Change in Pain Score at 60 minutes
Secondary: Change in Pain Score, Functional Status, Headache Medication Efficacy and Tolerability Perception by the Patient
Neurology